Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes

19 Jun 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Lung Cancer Research Studies
Share to Lung Cancer Treatments and Mutations

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 31228622
DOI: 10.1016/j.jtho.2019.06.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical OutcomesPMID 31228622Read ↗

Genotyping of RB1 status identifies two distinct subtypes in EGFR ‐mutant lung cancers with SCLC transformationSemantic proximity Read ↗

Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline MutationsSemantic proximity Read ↗

Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma.Semantic proximity Read ↗

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapySemantic proximity Read ↗

Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors.Semantic proximity Read ↗

Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations.Semantic proximity Read ↗

Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomesSemantic proximity Read ↗

Histological transformation in lung cancer: Mechanisms, clinical characteristics, and therapeutic approaches.Semantic proximity Read ↗

Lung Adenocarcinomas with HER2-Activating Mutations Are Associated with Distinct Clinical Features and HER2/EGFR Copy Number GainsSemantic proximity Read ↗

Simplified Molecular Classification of Lung Adenocarcinomas Based on EGFR, KRAS, and TP53 MutationsSemantic proximity Read ↗

A gene-alteration profile of human lung cancer cell lines.Semantic proximity Read ↗

Clinicogenomic analysis of EGFR-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.